PHARMACY

PQS launches next-generation EQUIPP platform

The redesigned EQUIPP facilitates pharmacies’ efforts to guide performance improvement.
Walgreens teams up with Health Corners, clinic partners expanding diabetes service access

Walgreens invests in training to equip pharmacists with expert knowledge to address the specific challenges of this chronic, complex condition.
Glenmark obtains FDA OK for generic Buphenyl

Buphenyl is used as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamyl phosphate synthetase.
Which industry has the most job quitters?

New research has revealed which industries are losing the most employees.
CVS Health to sell Omnicare

In an SEC filing on Wednesday CVS said that it is “determined that its LTC business was no longer a strategic asset, and during the third quarter of 2022 committed to a plan to sell.”
Gilead obtains FDA OK for new indication for Vemlidy

Vemlidy is now approved for the treatment of chronic Hepatitis B virus infection in pediatric patients.
Retailers reach agreements resolving opioid-related litigation

Walgreens and CVS Health separately announced agreements intended to resolve opioid-related litigation, while outlining initiatives taken to respond to the opioid crisis.
Amneal receives FDA nod for leuprolide acetate injection

Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.